Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Goodwill (2016 - 2024)

Historic Goodwill for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $45.6 billion.

  • Sanofi's Goodwill fell 1544.91% to $45.6 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $45.6 billion, marking a year-over-year decrease of 1544.91%. This contributed to the annual value of $46.4 billion for FY2024, which is 1325.05% down from last year.
  • Per Sanofi's latest filing, its Goodwill stood at $45.6 billion for Q2 2025, which was down 1544.91% from $46.4 billion recorded in Q4 2024.
  • Sanofi's 5-year Goodwill high stood at $55.0 billion for Q4 2021, and its period low was $45.6 billion during Q2 2025.
  • Moreover, its 5-year median value for Goodwill was $53.6 billion (2023), whereas its average is $51.9 billion.
  • Per our database at Business Quant, Sanofi's Goodwill soared by 866.97% in 2021 and then plummeted by 1544.91% in 2025.
  • Quarter analysis of 5 years shows Sanofi's Goodwill stood at $55.0 billion in 2021, then decreased by 7.41% to $50.9 billion in 2022, then rose by 4.43% to $53.2 billion in 2023, then fell by 12.78% to $46.4 billion in 2024, then dropped by 1.64% to $45.6 billion in 2025.
  • Its Goodwill stands at $45.6 billion for Q2 2025, versus $46.4 billion for Q4 2024 and $53.9 billion for Q2 2024.